PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Continente #
NA - Nord America 13.243
AS - Asia 7.423
EU - Europa 6.128
SA - Sud America 1.175
AF - Africa 173
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 28.165
Nazione #
US - Stati Uniti d'America 12.589
SG - Singapore 2.668
IT - Italia 1.685
CN - Cina 1.639
HK - Hong Kong 984
BR - Brasile 896
VN - Vietnam 893
RU - Federazione Russa 869
DE - Germania 851
SE - Svezia 576
CA - Canada 522
IE - Irlanda 519
UA - Ucraina 331
FR - Francia 312
GB - Regno Unito 280
IN - India 246
BD - Bangladesh 226
AT - Austria 214
FI - Finlandia 117
AR - Argentina 111
TR - Turchia 101
IQ - Iraq 98
KR - Corea 98
JP - Giappone 91
ID - Indonesia 78
NL - Olanda 71
MX - Messico 70
ES - Italia 67
DK - Danimarca 65
ZA - Sudafrica 60
PK - Pakistan 47
SA - Arabia Saudita 47
CO - Colombia 46
UZ - Uzbekistan 34
PL - Polonia 32
VE - Venezuela 30
EC - Ecuador 28
EG - Egitto 21
JM - Giamaica 21
PY - Paraguay 21
CH - Svizzera 19
PH - Filippine 19
CL - Cile 17
MA - Marocco 17
MY - Malesia 17
ET - Etiopia 16
NP - Nepal 16
BE - Belgio 15
DZ - Algeria 15
GR - Grecia 14
PE - Perù 14
PT - Portogallo 14
PS - Palestinian Territory 13
LT - Lituania 12
OM - Oman 12
TH - Thailandia 12
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
AU - Australia 10
CR - Costa Rica 9
KE - Kenya 9
PA - Panama 9
IL - Israele 8
IR - Iran 8
RO - Romania 8
AL - Albania 7
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LB - Libano 7
NO - Norvegia 7
UY - Uruguay 7
JO - Giordania 6
RS - Serbia 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
EU - Europa 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
BO - Bolivia 4
CY - Cipro 4
LV - Lettonia 4
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
HN - Honduras 3
HR - Croazia 3
MM - Myanmar 3
NG - Nigeria 3
NI - Nicaragua 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
EE - Estonia 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
Totale 28.125
Città #
Ann Arbor 2.328
Singapore 1.625
Ashburn 1.127
Hong Kong 963
Woodbridge 671
Fairfield 670
San Jose 663
Chandler 562
Dallas 519
Frankfurt am Main 503
Dublin 502
Houston 489
Wilmington 474
Milan 411
Toronto 374
New York 327
Seattle 300
Jacksonville 299
Beijing 276
Ho Chi Minh City 275
Dearborn 261
Cambridge 222
Santa Clara 209
Chicago 203
Princeton 195
Vienna 193
Los Angeles 192
The Dalles 188
Hefei 184
Hanoi 174
Nanjing 143
Rome 122
Lauterbourg 113
Altamura 92
Lawrence 92
São Paulo 91
Seoul 90
Council Bluffs 84
Moscow 77
Boardman 74
Buffalo 74
Shanghai 72
San Diego 55
Guangzhou 51
Jakarta 50
Tokyo 50
Dong Ket 48
Orem 47
Lachine 43
Nanchang 43
London 40
Helsinki 39
Baghdad 38
Da Nang 37
Falls Church 37
Haiphong 36
Munich 33
Lissone 32
Pune 32
Shenyang 32
Andover 31
Jinan 31
Tashkent 31
Brooklyn 30
Montreal 30
Nuremberg 30
Tianjin 29
Changsha 27
Columbus 27
Atlanta 26
Ottawa 26
Salt Lake City 25
San Francisco 25
Turin 25
Zhengzhou 25
Dhaka 23
Johannesburg 23
Naples 23
Denver 22
Jeddah 22
Warsaw 22
Phoenix 21
Rio de Janeiro 21
Tampa 21
Belo Horizonte 20
Chennai 20
Hebei 20
New Delhi 20
Manchester 19
Ningbo 19
Hangzhou 18
Istanbul 18
Florence 17
Kunming 17
Turku 17
Washington 17
Bologna 16
Brasília 16
Figino 16
Monza 16
Totale 18.148
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 706
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 509
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 506
The putative role of MALDI-MSI in the study of Membranous Nephropathy 432
Microscopic Polyangiitis 426
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 403
MALDI imaging in Fabry nephropathy: a multicenter study 399
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 398
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 386
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 382
Kidney Involvement 376
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 365
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 365
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 364
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 356
Proteomics for the study of new biomarkers in Fabry disease: State of the art 346
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 320
Usefulness of waist circumference for the identification of childhood hypertension 317
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 317
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 303
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 300
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 294
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 294
Obesity-associated hypertension in childhood: A new epidemic problem 292
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 288
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 284
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 281
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 279
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 278
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 277
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 273
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 263
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 261
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 258
Protein-Bound Uremic Toxins and Inflammation Process in Hemodialysis Patients: Is There a Role for Adsorption Hemodiafiltration? 256
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 255
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 251
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 248
Sympathetic activation in cardiovascular and renal disease 248
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 245
Parapelvic cysts, a distinguishing feature of renal Fabry disease 244
Role of fat distribution indicators in the identification of hypertension in children 243
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 243
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 241
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 240
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 239
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 238
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 237
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 232
Renal afferents signaling diuretic activity in the cat 231
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 230
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 228
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 227
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 227
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 225
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 223
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 223
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 222
Tumour incidence in Fabry disease: A cross-sectional study 221
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 218
Anticoagulant-related nephropathy: a pathological note 218
Interpretation of GFR slope in untreated and treated adult Fabry patients 216
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 213
ANCA-associated vasculitis in childhood: Recent advances 212
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 211
La terapia enzimatica sostitutiva nella malattia di Fabry 210
Avacopan for the treatment of ANCA-associated vasculitis 210
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 209
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 204
Redefining the pulvinar sign in fabry disease 204
Analysis of heart period and arterial pressure variability in childhood hypertension: Key role of baroreflex impairment 201
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 201
Hypertension in childhood: autonomic and metabolic patterns 200
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 198
[Clinical and histological findings in Fabry nephropathy] 198
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 193
La diagnosi precoce di malattia 193
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 188
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 185
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 185
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 184
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 184
PICC insertion and veins of the arm size variation during dialysis treatment: A prospective observational study 182
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 182
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial 181
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 180
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 179
Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study 177
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 177
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 176
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 176
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 175
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 175
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 170
Cardiovascular magnetic resonance insights into anomalies of the mitral valve apparatus in Fabry cardiomyopathy and hypertrophic cardiomyopathy 165
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 165
Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis 164
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 163
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 160
The children of dialysis: Live-born babies from on-dialysis mothers in Italy - An epidemiological perspective comparing dialysis, kidney transplantation and the overall population 160
Totale 25.557
Categoria #
all - tutte 93.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.614 155 198 187 148 115 140 47 81 73 91 117 262
2022/20232.290 255 725 192 177 154 357 27 115 157 15 55 61
2023/20241.660 56 46 53 81 191 506 288 56 119 31 42 191
2024/20254.413 266 395 261 189 345 148 270 133 511 813 402 680
2025/202610.804 1.145 705 1.059 976 1.185 499 1.470 550 840 815 739 821
2026/2027108 108 0 0 0 0 0 0 0 0 0 0 0
Totale 28.779